XML 18 R13.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Commitments (Tables)
3 Months Ended
Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
Schedule of exercisable share purchase warrants outstanding

A summary of the status of the Company’s outstanding share purchase warrants is presented below:

 

    Number of Shares   Weighted Average Exercise Price ($)
Balance, September 30, 2018     678,379     2.87
Exercised     (8,750 )   1.13
Expired     (319,629 )   1.46
Balance, September 30, 2019     350,000     4.19
Granted     150,000     3.17
Balance, December 31, 2019     500,000     3.88
Schedule of share purchase warrants outstanding

At December 31, 2019, the Company had share purchase warrants outstanding as follows:

 

Number   Exercise Price   Expiry Date
  350,000     $ 4.19     June 30, 2021
  150,000     $ 3.17     May 6, 2024
  500,000              
Schedule of outstanding stock purchase options

A summary of the status of Company’s outstanding stock purchase options is presented below:

 

   Number of Shares  Weighted Average Exercise Price ($)  Weighted Average Grant Date Fair Value ($)  Aggregate intrinsic value ($)
Outstanding, September 30, 2018   6,506,917    3.83        2,353,088
Granted   2,265,399    2.79    2.27 
Forfeited   (309,383)   3.25      
Outstanding, September 30, 2019   8,462,933    3.58        4,115,032
Granted   265,000    2.36    1.98 
Forfeited   (1,667)   2.64      
Outstanding, December 31, 2019   8,726,266    3.54        2,195,111
Exercisable, December 31, 2019   5,883,586    3.85        2,047,275
Schedule of general and administrative expenses and research and development expenses

These amounts have been included in general and administrative expenses and research and development expenses on the Company’s statement of operations as follows:

 

   2019  2018
General and administrative  $481,101   $1,011,399 
Research and development   783,323    1,055,588 
Total share based compensation  $1,264,424   $2,066,987 
Schedule of weighted average assumptions for fair value of each option award

The fair value of each option award is estimated on the date of grant using the Black Scholes option pricing model based on the following weighted average assumptions:

 

   2019  2018
Risk-free interest rate   1.88%   2.96%
Expected life of options (years)   5.21    5.45 
Annualized volatility   101.60%   106.15%
Dividend rate   0.00%   0.00%